Vascade VCS Provides Temporary Hemostasis During Vascular Closure


February 7, 2013
Cardiva Medical FDA Pre Market Approval Vascade VCS

Cardiva Medical's Vascade Vascular Closure System (VCS), an extravascular closure device, utilizes a unique delivery system based on a proprietary collapsible disc technology that provides temporary hemostasis during vascular closure, which eliminates the need for an intra-vascular component. Secure and rapid hemostasis is achieved with Vascade by the deployment of a thrombogenic resorbable collagen patch at the arteriotomy of the femoral artery.

The sytem received FDA PMA in February 2013

For more information:

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.